[
  {
    "ts": null,
    "headline": "INGN Stock Gains Post Latest Launch to Expand Respiratory Care Suite",
    "summary": "Inogen launches Aurora CPAP masks to expand its respiratory care suite and enter the growing sleep apnea market.",
    "url": "https://finnhub.io/api/news?id=4c59ff84237ab4d59b65de22ef5fd2c371ae0f331680faeac332c0b617895158",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767883560,
      "headline": "INGN Stock Gains Post Latest Launch to Expand Respiratory Care Suite",
      "id": 138038458,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Inogen launches Aurora CPAP masks to expand its respiratory care suite and enter the growing sleep apnea market.",
      "url": "https://finnhub.io/api/news?id=4c59ff84237ab4d59b65de22ef5fd2c371ae0f331680faeac332c0b617895158"
    }
  },
  {
    "ts": null,
    "headline": "Here's Why You Should Hold Avantor Stock in Your Portfolio for Now",
    "summary": "AVTR looks worth holding as its broad portfolio, strategic deals and cost savings offset Lab Solutions' weakness for now with AI tools and strong cash flow.",
    "url": "https://finnhub.io/api/news?id=2595495de515af1e304f0f62a4f0c8b24aeef97a466354d276505ae573c2b048",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767878940,
      "headline": "Here's Why You Should Hold Avantor Stock in Your Portfolio for Now",
      "id": 138036813,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "AVTR looks worth holding as its broad portfolio, strategic deals and cost savings offset Lab Solutions' weakness for now with AI tools and strong cash flow.",
      "url": "https://finnhub.io/api/news?id=2595495de515af1e304f0f62a4f0c8b24aeef97a466354d276505ae573c2b048"
    }
  },
  {
    "ts": null,
    "headline": "Is Boston Scientific Stock a Smart Pick for Your Portfolio Right Now?",
    "summary": "BSX is seeing solid international growth, MedSurg market-share gains and surging WATCHMAN sales, though macro and competition remain risks.",
    "url": "https://finnhub.io/api/news?id=2d12c005391349579ff478a4fe46ec854dd30687d56e86bb0a1d0ee8a4fe2e90",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767878820,
      "headline": "Is Boston Scientific Stock a Smart Pick for Your Portfolio Right Now?",
      "id": 138036814,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "BSX is seeing solid international growth, MedSurg market-share gains and surging WATCHMAN sales, though macro and competition remain risks.",
      "url": "https://finnhub.io/api/news?id=2d12c005391349579ff478a4fe46ec854dd30687d56e86bb0a1d0ee8a4fe2e90"
    }
  },
  {
    "ts": null,
    "headline": "Here's Why You Should Retain Cencora Stock in Your Portfolio Now",
    "summary": "Cencora's strength in U.S. Healthcare Solutions, along with rising specialty drug demand and biosimilar adoption, supports growth, though competitive pressures and international weakness remain headwinds.",
    "url": "https://finnhub.io/api/news?id=acba523b0bb1121aadcc7df919350e27aad2579cb4cc1562ecc763ade9fd959f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767877020,
      "headline": "Here's Why You Should Retain Cencora Stock in Your Portfolio Now",
      "id": 138036815,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Cencora's strength in U.S. Healthcare Solutions, along with rising specialty drug demand and biosimilar adoption, supports growth, though competitive pressures and international weakness remain headwinds.",
      "url": "https://finnhub.io/api/news?id=acba523b0bb1121aadcc7df919350e27aad2579cb4cc1562ecc763ade9fd959f"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Earnings Preview: What to Expect",
    "summary": "Boston Scientific will release its fourth-quarter earnings next month, and analysts anticipate a low double-digit bottom-line growth.",
    "url": "https://finnhub.io/api/news?id=f408c38e74ab2fb7d0d2482923001ebb6803a5d8b31b9d856dd231604a382558",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767869930,
      "headline": "Boston Scientific Earnings Preview: What to Expect",
      "id": 138036816,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific will release its fourth-quarter earnings next month, and analysts anticipate a low double-digit bottom-line growth.",
      "url": "https://finnhub.io/api/news?id=f408c38e74ab2fb7d0d2482923001ebb6803a5d8b31b9d856dd231604a382558"
    }
  },
  {
    "ts": null,
    "headline": "Is Boston Scientific (BSX) Pricing Reflect Long Term Growth Expectations After Strong Multi Year Run",
    "summary": "If you are wondering whether Boston Scientific's current share price lines up with its underlying worth, you are not alone. This article focuses on what the numbers may say about value. The stock last closed at US$98.65, with returns of 3.5% over 7 days, 5.1% over 30 days, 4.2% year to date, 2.8% over 1 year, 115.3% over 3 years and 173.6% over 5 years, which many investors look at when weighing growth potential against risk. Recent attention on Boston Scientific has centered on how its...",
    "url": "https://finnhub.io/api/news?id=f44ac6edd39483df3033e6aaabf14650c3e1c89792e615c2a0188f04fdc65bb9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767834733,
      "headline": "Is Boston Scientific (BSX) Pricing Reflect Long Term Growth Expectations After Strong Multi Year Run",
      "id": 138033385,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "If you are wondering whether Boston Scientific's current share price lines up with its underlying worth, you are not alone. This article focuses on what the numbers may say about value. The stock last closed at US$98.65, with returns of 3.5% over 7 days, 5.1% over 30 days, 4.2% year to date, 2.8% over 1 year, 115.3% over 3 years and 173.6% over 5 years, which many investors look at when weighing growth potential against risk. Recent attention on Boston Scientific has centered on how its...",
      "url": "https://finnhub.io/api/news?id=f44ac6edd39483df3033e6aaabf14650c3e1c89792e615c2a0188f04fdc65bb9"
    }
  }
]